Cargando…

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer

SIMPLE SUMMARY: In breast cancer development, the expression of Ki-67 is strongly associated with cancer proliferation and is a known indicator of prognosis and outcome. Ki-67 expression levels are also useful to inform treatment decision making in some cases. As a result, routine measurement of Ki-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davey, Matthew G., Hynes, Sean O., Kerin, Michael J., Miller, Nicola, Lowery, Aoife J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430879/ https://www.ncbi.nlm.nih.gov/pubmed/34503265 http://dx.doi.org/10.3390/cancers13174455

Ejemplares similares

The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment
por: Davey, Matthew G., et al.
Publicado: (2021)

MicroRNA Expression Profiles and Breast Cancer Chemotherapy
por: Davey, Matthew G., et al.
Publicado: (2021)

Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Ki-67 biomarker in breast cancer of Indian women
por: Patil, Amit V., et al.
Publicado: (2011)

Ki67 and breast cancer mortality in women with invasive breast cancer
por: Probert, Jake, et al.
Publicado: (2023)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
por: Richard, Vinitha, et al.
Publicado: (2021)

Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
por: Davey, Matthew G, et al.
Publicado: (2022)

Dysregulated miR-183 inhibits migration in breast cancer cells
por: Lowery, Aoife J, et al.
Publicado: (2010)

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.
por: Railo, M., et al.
Publicado: (1993)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

New Insight into Ki67 Expression at the Invasive Front in Breast Cancer
por: Gong, Peng, et al.
Publicado: (2013)

Assessment of Ki-67 as a potential biomarker in patients with breast cancer
por: Ragab, Halla Mohamed, et al.
Publicado: (2018)

Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
por: Soliman, Nahed A., et al.
Publicado: (2016)

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
por: Magnusson, Kristina, et al.
Publicado: (2016)

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
por: Kerin, Eoin P., et al.
Publicado: (2022)

The prognostic importance of PD-L1, PTEN, PHH3, and KI-67 expressions in invasive breast carcinoma
por: Imamoglu, Eda Hilal, et al.
Publicado: (2022)

Gastrointestinal Stromal Tumor and Ki-67 as a Prognostic Indicator
por: Kadado, Kevin J, et al.
Publicado: (2022)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Molecular subtyping of ependymoma and prognostic impact of Ki-67
por: Lim, Ka Young, et al.
Publicado: (2021)

Semi-automated evaluation of Ki-67 index in invasive ductal carcinoma of the breast
por: SUCIU, CRISTIAN, et al.
Publicado: (2014)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters
por: Hashmi, Atif Ali, et al.
Publicado: (2019)

Prognostic impact of Ki-67 in patients with gastric cancer—the importance of depth of invasion and histologic differentiation
por: Ko, Gyung Hyuck, et al.
Publicado: (2017)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

Association of Ki-67 With Clinicopathological Factors in Breast Cancer
por: ., Nishit, et al.
Publicado: (2021)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

Ki67 immunostaining in primary breast cancer: pathological and clinical associations.
por: Bouzubar, N., et al.
Publicado: (1989)

Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer
por: Davoren, Pamela A, et al.
Publicado: (2008)

The double agents in liquid biopsy: promoter and informant biomarkers of early metastases in breast cancer
por: Richard, Vinitha, et al.
Publicado: (2022)

Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer
por: Jacquemier, Jocelyne, et al.
Publicado: (2009)

Ki67 expression in breast cancer: Correlation with prognostic markers and clinicopathological parameters in Saudi patients
por: Elkablawy, Mohamed A., et al.
Publicado: (2016)

The Prognostic Potential of Neurokinin 1 Receptor in Breast Cancer and Its Relationship with Ki-67 Index
por: Al-Keilani, Maha S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_of59bqkplkve4ipt42e6ppm6g8